Summary
Sequenom Inc (Sequenom) is a life sciences company which offers genetic testing that guides reproductive health matters. The company operates CAP (College of American Pathologists) accredited and CLIA (Clinical Laboratory Improvements Amendment) certified molecular diagnostics clinical laboratory (MDCL) that specializes in the field of in prenatal health. Sequenom offers wide collection of carrier status, noninvasive prenatal testing, and diagnostic test options ranging from baby’s whole genome assessment to specific conditions identification which allows parents and physicians to select the right test for each pregnancy. The molecular genetic laboratory-developed tests offer early patient management information for geneticists, maternal fetal medicine specialists, and obstetricians as well as patients. Its MDCLs are located at San Diego, California; Raleigh-Durham, North Carolina; and Grand Rapids, Michigan. Sequenom is headquartered in San Diego, California, the US.
Sequenom Inc (SQNM) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Sequenom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Sequenom Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Sequenom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Sequenom Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Sequenom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Sequenom Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 11
Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 12
Partnerships 13
Sequenom enters into an Agreement with University of California 13
Sequenom Enters into Licensing Agreement with Mayo Medical Labs 13
Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 14
Sequenom Enters Into Licensing Agreement With LifeCodexx 15
Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 16
Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 16
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 17
New England Biolabs Enters Into Licensing Agreement With Sequenom 18
Equity Offering 19
Sequenom Completes Public Offering Of Common Stock For US$62 Million 19
Debt Offering 20
Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 20
Asset Transactions 22
Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 22
Acquisition 22
LabCorp Acquires Sequenom 22
Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 24
Sequenom Inc - Key Competitors 26
Key Employees 27
Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Strategy And Business Planning 30
Mar 02, 2016: Sequenom Announces Contract with Anthem BlueCross 30
Jan 07, 2016: Sequenom Announces Restructuring: Plans Sale Of North Carolina Operations And Initiatives To Improve Efficiencies 31
Financial Announcements 32
May 04, 2016: Sequenom Reports First Quarter 2016 Results 32
Mar 02, 2016: Sequenom Reports 2015 Financial Results 34
Jan 11, 2016: Sequenom Announces Preliminary 2015 Results 36
Corporate Communications 37
Apr 12, 2016: Sequenom Strengthens Executive Team with New Vice President of Sales 37
Legal and Regulatory 38
Jun 27, 2016: The Supreme Court Of The United States Denies Sequenom's Petition Requesting Review Of Decision On '540 Patent 38
Mar 21, 2016: Sequenom Files Petition With the Supreme Court of the United States Requesting Review Of Decision On '540 Patent 39
Product News 40
Feb 25, 2016: Sequenom Laboratories Announces Positive Results from Clinical Validation Study on the MaterniT GENOME Test 40
Jan 11, 2016: Sequenom Provides Update On MaterniT Genome Test 41
Other Significant Developments 42
May 03, 2016: Sequenom Announces In-Network Contracts with Anthem Blue Cross and Blue Shield Plans for Georgia, Indiana, Kentucky, Missouri, Ohio, Virginia and Wisconsin 42
Apr 19, 2016: Sequenom Completes Consolidation of North Carolina Operations 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
List of Tables
Sequenom Inc, Medical Equipment, Key Facts, 2015 1
Sequenom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Sequenom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Sequenom Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Sequenom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Sequenom Inc, Deals By Market, 2011 to YTD 2017 9
Sequenom Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 11
Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 12
Sequenom enters into an Agreement with University of California 13
Sequenom Enters into Licensing Agreement with Mayo Medical Labs 13
Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 14
Sequenom Enters Into Licensing Agreement With LifeCodexx 15
Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 16
Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 16
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 17
New England Biolabs Enters Into Licensing Agreement With Sequenom 18
Sequenom Completes Public Offering Of Common Stock For US$62 Million 19
Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 20
Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 22
LabCorp Acquires Sequenom 22
Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 24
Sequenom Inc, Key Competitors 26
Sequenom Inc, Key Employees 27
Sequenom Inc, Other Locations 28
Sequenom Inc, Subsidiaries 28
List of Figures
Sequenom Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Sequenom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Sequenom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Sequenom Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Sequenom Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Sequenom Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
Sequenom Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Sequenom Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
